Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease

Clinical Neurophysiology

Volumn 115, Issue 1, 2004, Pages 39-49

  Rodriguez, Guido ^a   Vitali, Paolo ^b   Canfora, Michela ^b   Calvini, Piero ^a   Girtler, Nicola ^a   De Leo, Caterina ^a   Piccardo, Arnoldo ^a   Nobili, Flavio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Acetylcholinesterase inhibitor; Alzheimer's disease; Brain single photon emission computed tomography; Donepezil; Quantitative EEG; Statistical parametric mapping

Indexed keywords

DONEPEZIL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BRAIN PERFUSION; BRAIN REGION; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; ELECTRONEUROLOGY; FEMALE; FOURIER TRANSFORMATION; FRONTAL LOBE; HUMAN; LONG TERM CARE; MALE; MINI MENTAL STATE EXAMINATION; OCCIPITAL LOBE; PARIETAL LOBE; POWER SPECTRUM; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS;

EID: 0346099135     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-2457(03)00321-3     Document Type: Article

References (58)

1. Alavi A., Jolles P.R., Jamieson D.G., Reivich M., Chawluk J. Anatomic and functional changes of the brain in normal aging and dementia as demonstrated by MRI, CT and PET. Nuclear Medicine Annual. 1989;Raven, New York.
2. Baldini D., Calvini P., Formiconi A.R. Image reconstruction with conjugate gradient algorithm and compensation of the variable system response for an annular SPECT system. Phys Med. 14:1998;159-173.
3. Boccacci P., Bonetto P., Calvini P., Formiconi A.R. A simple model for the efficient correction of collimator blur in 3D SPECT imaging. Inverse Problems. 15:1999;907-930.
4. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 16:1995;271-278.
5. Buchan R.J., Nagata K., Yokoyama E., Langman P., Yuya H., Hirata Y., Hatazawa J., Kanno I. Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type. Electroenceph clin Neurophysiol. 103:1997;409-417.
6. Charpentier P., Lavenu I., Defebvre L., Duhamel A., Lecouffe P., Pasquier F., Steinling M. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to 99m Tc HMPAO SPECT data. J Neurol Neurosurg Psychiatry. 69:2000;661-663.
7. Dooley M., Lamb H.M. Donepezil: a review of its use in Alzheimer's disease. Drugs Aging. 16:2000;199-226.
8. Duffy F.H., Albert M.S., McAnulty G. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer's type. Ann Neurol. 16:1984;439-448.
9. Feldman H., Gauthier S., Hecker J., Vellas B., Subbiah P., Whalen E. Donepezil MSAD Study Investigators Group. A 24-week, randomised, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 57:2001;613-620.
10. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-198.
11. Formiconi A., Passeri A., Pupi A. Compensation of spatial system response in SPECT with conjugate gradient reconstruction technique. Phys Med Biol. 34:1989;69-84.
12. Friston K.J., Frith C.D., Liddle P.F. Comparing functional (PET) images: the assessment of significant changes. J Cereb Blood Flow Metab. 11:1991;690-699.
13. Genna S., Smith A.P. The development of ASPECT, an annular single crystal brain camera for high efficiency SPECT. IEEE Trans Nucl Sci. NS-35:1988;654-658.
14. Han L., Cole M., Bellevance F., McCusker J., Primeau F. Tracking cognitive decline in Alzheimer's disease using the Mini-Mental Stare Examination: a meta-analysis. Int Psychogeriatr. 12:2000;231-247.
15. Holl G., Straschill M., Thomsen T., Fischer J.P., Kewitz H. Effect of the cholinesterase inhibiting substance galanthamine on human EEG and visual evoked potentials. Electroenceph clin Neurophysiol. 82:1992;445-452.
16. Ibanez V., Pietrini P., Alexander G.E., Furey M.L., Teichberg D., Rajapakse J.C., Rapoport S.I., Schapiro M.B., Horwitz B. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology. 50:1998;1585-1593.
17. 15 positron emission tomography. Eur J Nucl Med. 24:1997;670-673.
18. Jelic V., Johansson S.E., Almkvist O., Shigeta M., Julin P., Nordberg A., Winblad B., Wahlund L.O. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging. 21:2000;533-540.
19. Juni J.E., Waxman A.D., Devous M.D. Sr, Tikofsky R.S., Ichise M., Van Heertum R.L., Holman B.L., Carretta R.F., Chen C.C. Procedure guidelines for brain perfusion SPECT using Technetium-99m radiopharmaceuticals. J Nucl Med. 39:1998;923-926.
20. Kim H., Kim S., Go H., Kim D. Synergetic analysis of spatio-temporal EEG patterns: Alzheimer's disease. Biol Cybern. 85:2001;1-17.
21. Knott V., Mohr E., Mahoney C., Ilivitsky V. Pharmaco-EEG test dose response predicts cholinesterase inhibitor treatment outcome in Alzheimer's disease. Methods Find Exp Clin Pharmacol. 22:2000;115-122.
22. Kogan E.A., Korczyn A.D., Virchovsky R.G., Klimovizky S.S.H., Treves T.A., Neufeld M.Y. EEG changes during long-term treatment with donepezil in Alzheimer's disease patients. J Neural Transm. 108:2001;1167-1173.
23. Kogure D., Matsuda H., Ohnishi T., Asada T., Uno M., Kunihiro T., Nakano S., Takasaki M. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med. 41:2000;1155-1162.
24. Leuchter A.F., Spar J.E., Walter D.O., Weiner H. Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's type and multi-infarct dementia. Arch Gen Psychiatry. 44:1987;993-998.
25. Liepert J., Bar M.J., Meske U., Weiller C. Motor cortex disinhibition in Alzheimer's disease. Clin Neurophysiol. 112:2001;1436-1441.
26. Maddock R.J., Garret A.S., Buonocore M.H. Remembering familial people: the posterior cingulate cortex and autobiographical memory retrieval. Neuroscience. 104:2001;667-676.
27. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med. 15:2001;85-92.
28. Matsuda H., Kitayama N., Ohnishi T., Asada T., Nakano S., Sakamoto S., Imabayashi E., Katoh A. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med. 43:2002;304-311.
29. Mayeux R., Sano M. Treatment of Alzheimer's disease. N Engl J Med. 341:1999;1670-1679.
30. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
31. McKeith I.G., Perry E.K., Perry R.H. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology. 53:1999;902-905.
32. Minoshima S., Foster N.L., Kuhl D.E. Posterior cingulate cortex in Alzheimer's disease. Lancet. 334:1994;895.
33. Minoshima S., Giordani B., Berent S., Frey K., Foster N.L., Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 42:1997;85-94.
34. Nakano S., Asada T., Matsuda H., Uno M., Takasaki M. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med. 42:2001;1441-1445.
35. Nobili F., Vitali P., Calvini P., Bollati F., Girtler N., Delmonte M., Mariani G., Rodriguez G. Clinical correlative evaluation of an iterative method for reconstruction of brain SPECT images. Nucl Med Biol. 28:2001;627-632.
36. Nobili F., Koulibaly M., Vitali P., Migneco O., Mariani G., Ebmeier K., Pupi A., Robert P.H., Rodriguez G., Darcourt J. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors. J Nucl Med. 43:2002;983-990.
37. Nobili F., Vitali P., Canfora M., Girtler N., De Leo C., Mariani G., Pupi A., Rodriguez G. Effects of long-term donepezil therapy on rCBF of Alzheimer's patients. Clin Neurophysiol. 113:2002;1241-1248.
38. Nordberg A., Amberla K., Shigeta M., Lundqvist H., Viitanen M., Hellstrom-Lindahl E., Johansson M., Andersson J., Hartvig P., Lilja A., Langstrom B., Winblad B. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities. Alzheimer Dis Assoc Disord. 12:1998;228-237.
39. Oda K., Okubo Y., Ishida R., Murata Y., Ohta K., Matsuda T., Matsushima E., Ichimiya T., Suhara T., Shibuya H., Nishikawa T. Regional cerebral blood flow in depressed patients with white matter magnetic resonance hyperintensity. Biol Psychiatry. 53:2003;150-156.
40. Potkin S.G., Anand R., Fleming K., Alva G., Keator D., Carreon D., Messina J., Wu J.C., Hartman R., Fallon J.H. Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease. Int J Neuropsychopharmacol. 4:2001;223-230.
41. Prichep L.S., John E.R., Ferris S.R., Reisberg B., Almas M., Alper K., Cancro R. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging. 15:1994;85-90.
42. Prvulovic D., Hubl D., Sack A.T., Melillo L., Maurer K., Frolich L., Lanfermann H., Zanella F.E., Goebel R., Linden D.E.J., Dierks T. Functional imaging of visuospatial processing in Alzheimer's disease. Neuroimage. 17:2002;1403-1414.
43. Reeves R.R., Struve F.A., Patrik G., Booker J.G., Nave D.W. The effects of donepezil on the P300 auditory and visual cognitive evoked potentials of patients with Alzheimer's disease. Am J Geriatr Psychiatry. 7:1999;349-352.
44. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the E4 allele for apolipoprotein E. N Engl J Med. 334:1996;752-758.
45. Rodriguez G., Nobili F., Rocca G., De Carli F., Gianelli M.V., Rosadini G. Quantitative electroencephalography and regional cerebral blood flow: discriminant analysis between Alzheimer's patients and healthy controls. Dement Geriatr Cogn Disord. 9:1998;274-283.
46. Rodriguez G., Nobili F., Copello F., Vitali P., Taddei G., Catsafados E., Mariani G. 99mTc-HMPAO SPECT and quantitative electroencephalography in Alzheimer's disease. A correlative study. J Nucl Med. 40:1999;522-529.
47. Rodriguez G., Copello F., Vitali P., Perego G., Nobili F. EEG spectral profile to stage Alzheimer's disease. Clin Neurophysiol. 110:1999;1831-1837.
48. Rodriguez G., Vitali P., De Leo C., De Carli F., Nobili F. Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy. Neuropsychobiology. 46:2002;49-56.
49. Rogers S.L., Farlow M.R., Doody R.S., Mohs R., Friedhoff L.T. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology. 50:1998;136-145.
50. Shinotoh H., Namba H., Fukushi K., Nagatsuka S., Tanaka N., Aotsuka A., Tanada S., Irie T. Brain acetylcholinesterase activity in Alzheimer's disease measured by positron emission tomography. Alzheimer Dis Assoc Disord. 14:2000;S114-S118.
51. Staff R.T., Gemmel H.G., Shanks M.F., Murray A.D., Venneri A. Changes in the rCBF images of patients with Alzheimer's disease receiving donepezil therapy. Nucl Med Commun. 21:2000;37-41.
52. Talairach J., Tournoux P. Co-planar stereotaxic atlas of the human brain. 1988;Thieme Medical, New York.
53. Thomas A., Iacono D., Bonanni L., D'Andreamatteo G., Onofrj M. Donepezil, rivastigmine, and Vitamin E in Alzheimer's disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months. Clin Neuropharmacol. 24:2001;31-42.
54. Tukey J.W. Discussion, emphasizing the connection between analysis of variance and spectral analysis. Technometrics. 3:1961;191-219.
55. Vander Borght K., Minoshima S., Giordani B., Foster N.L., Frey K.A., Berent S., Albin L., Koeppe R.A., Kuhl D.E. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med. 38:1997;797-802.
56. Venneri A., Shanks M.F., Staff R.T., Pestell S.J., Forbes K.E., Gemmel H.G., Murray A.D. Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease. Neuroreport. 13:2002;83-87.
57. Wolf H., Jelic V., Gertz H.J., Nordberg A., Julin P., Wahlund L.O. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand Suppl. 179:2003;52-76.
58. Yang D.W., Kim B.S., Park J.K., Kim S.Y., Kim E.N., Sohn H.S. Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: adaptation of statistical parametric mapping. J Neurol Sci. 203-204:2002;199-205.